Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection
Lubetzky, M.; Auli, M.J.; Walker, J.; Leeser, D.; Kapur, S.; Hartono, C.; Dadhania, D.
Clinical Transplants 2010: 437-440
2010
ISSN/ISBN: 0890-9016 PMID: 21696061 Document Number: 647813
Document emailed within 1 workday
Related Documents
Hardinger, K.L.; Alford, K.; Murillo, D. 2010: Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience Clinical Transplants 2010: 429-436Wong, W.; Lee, R-Ann.; Saidman, S.L.; Smith, R.Neal.; Zorn, E. 2009: Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports Clinical Transplants 2009: 401-405
Schwaiger, E.; Regele, H.; Wahrmann, M.; Werzowa, J.; Haidbauer, B.; Schmidt, A.; Böhmig, G.A. 2010: Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report Clinical Transplants 2010: 391-396
Leyva, S.; Marino-Vázquez, L.A.; Reyes-Loaeza, J.A.; Vega, O.; Uribe-Uribe, N.; Alberú, J.; Morales-Buenrostro, L.E. 2009: Bortezomib for antibody mediated rejection treatment: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City Clinical Transplants 2009: 369-376
Cooper, J.E.; Wiseman, A.C.; Chan, L. 2009: Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases Clinical Transplants 2009: 455-459
Cooper, J.E.; Wiseman, A.C.; Chan, L. 2010: Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases Clinical Transplants 2010: 415-420
Lee, I.; Constantinescu, S.; Gillespie, A.; Swami, A.; Birkenbach, M.; Leech, S.; Silva, P.; Karachristos, A.; Daller, J.A.; Sifontis, N.M. 2009: Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line? Clinical Transplants 2009: 425-429
Gautreau, C.; Suberbielle, C.; Andrade, J.; Charron, D. 2006: Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation Clinical Transplants 2006: 502
Haiyan, X.; Xiaozhou, H.; Wei, Z.; Hui, G.; Qianqian, S.; Yibei, Z.; Xueguang, Z. 2012: CD256 Can be Found in Antibody-Mediated Renal Allograft Rejection Tissues Clinical Laboratory 58(5-6): 411-418
Yuan, Z.-g.; Hou, J.; Wang, D.-x.; Fu, W.-j.; Chen, Y.-b.; Xi, H. 2008: Bortezomib-based combination therapy for relapsed or refractory multiple myeloma Zhonghua Nei Ke Za Zhi 47(2): 102-106
Capel, P.J.; de Waal, R.M.; Démant, P.; Koene, R.A. 1981: Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies Transplantation Proceedings 13(1 Part 1): 649-653
Karakoz, I.; Hasek, M.; Kohoutová, L. 1976: The role of bursa of Fabricius and thymus in antibody-mediated allograft rejection in ducks Folia Biologica 22(5): 304-311
Pierson, R.N.; Kaspar-König, W.; Tew, D.N.; Young, V.K.; Braidley, P.C.; White, D.J.; Wallwork, J. 1995: Profound pulmonary hypertension characteristic of pig lung rejection by human blood is mediated by xenoreactive antibody independent of complement Transplantation Proceedings 27(1): 274
Schadde, E.; d'Alessandro, A.M.; Musat, A.I.; Torrealba, J.R.; Knechtle, S.J. 2006: Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin Clinical Transplants 2006: 479-482
Hardinger, K.L.; Alford, K.; Murillo, D. 2009: Bortezomib for acute humoral rejection in two repeat transplant recipients Clinical Transplants 2009: 479-483
Boonkitticharoen, V.; Puchinda, D.; Chouplywech, P.; Jalayondeja, W. 1998: Reduction-mediated 99mTc-labeling of antitumor monoclonal antibodies: effect of increasing specific activity on antibody binding kinetics Journal of the Medical Association of Thailand 81(10): 741-749
Kormos, R.L.; Herlan, D.B.; Armitage, J.M.; Stein, K.; Kaufman, C.; Zeevi, A.; Duquesnoy, R.; Hardesty, R.L.; Griffith, B.P. 1990: Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation Journal of Heart Transplantation 9(1): 1-9; Discussion: 9-10
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793
Lonze, B.E.; Dagher, N.N.; Simpkins, C.E.; Singer, A.L.; Segev, D.L.; Zachary, A.A.; Montgomery, R.A. 2009: The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib Clinical Transplants 2009: 377-384
Bright, R.K.; Shearer, M.H.; Kennedy, R.C. 1994: Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity Journal of Immunology 153(5): 2064-2071